Imaging Technology

JULY 11, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This further strengthens our commitment to production and development of novel radiopharmaceuticals to advance cancer treatments and quality of life for cancer patients."

Radiopharmaceuticals 68

Radiopharmaceuticals Imaging Pharmaceutical Disease 68

AuntMinnie

MAY 1, 2024

Food and Drug Administration (FDA) has approved Novartis' Lutathera (lutetium-177 [Lu-177]) DOTATATE radiopharmaceutical for treatment of pediatric patients who are 12 years old and older with somatostatin receptor (SSTR)-positive gastroentropancreatic neuroendocrine tumors (GEP-NETs).

Radiopharmaceuticals 88

Radiopharmaceuticals Pharmaceutical Radiology 88

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 73

Pharmaceutical Radiopharmaceuticals Clinic Medical 73

AuntMinnie

APRIL 13, 2023

Fusion Pharmaceuticals has secured clearance from the U.S. Read more on AuntMinnie.com Related Reading: Fusion heralds FDA tumor therapy clearance Fusion and Niowave ink $5M collaboration Fusion Pharmaceuticals to build radiopharma plant in Canada Fusion buys radiopharmaceutical from Ipsen Food and Drug Administratio.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JUNE 10, 2024

Evans, a professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, was recognized for his work in biomarker discovery and radiopharmaceutical development. He has published more than 90 peer-reviewed articles and is a co-inventor on 13 patents pending or issued.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

AuntMinnie

JUNE 23, 2023

Radiopharmaceutical developer Actinium Pharmaceuticals is highlighting six researc. Read more on AuntMinnie.com Related Reading: Actinium, Astellas to create actinium-225 radiotherapies Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JANUARY 24, 2024

TerraPower Isotopes has shipped its first samples of Actinium-225 (Ac-225) to two pharmaceutical companies to develop targeted cancer treatments in drug trials. Global demand for Ac-225 is expected to increase as more radiopharmaceutical treatments using Actinium-225 are developed, the company noted.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Radiation Oncology IT 52

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 77

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 77

Imaging Technology

APRIL 13, 2023

He has more than 22 years of operational and commercial expertise in radioisotopes and radiopharmaceuticals. actinium-225 (Ac-225), and drive business development initiatives for NorthStar’s Radiopharmaceutical CDMO/CMO business units. Ac-225 and Cu-67 using environmentally preferable technologies. SPECT franchise.

Radiopharmaceuticals 69

Radiopharmaceuticals Medical Pharmaceutical Nuclear Medicine 69

AuntMinnie

JULY 19, 2023

Read more on AuntMinnie.com Related Reading: NorthStar manufactures Cu-67 for Clarity Pharmaceuticals NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc. facility NorthStar produces first Mo-99 batch at new facility NorthStar and Inhibrx ink deal on radiopharmaceutical development

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical IT 52

AuntMinnie

JULY 24, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitmen.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 88

Medical Radiopharmaceuticals Pharmaceutical Radiation 88

Imaging Technology

NOVEMBER 26, 2023

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy.

Clinic 54

Clinic Radiopharmaceuticals Radiosensitivity Pharmaceutical 54

Imaging Technology

FEBRUARY 14, 2024

PanTera is committed to supporting the pharmaceutical industry by scaling up production to meet the significant global demand for targeted radiopharma-based therapeutics in the fight against cancer.”

Pharmaceutical 81

Pharmaceutical Radiopharmaceuticals Medical Clinic 81

Imaging Technology

APRIL 24, 2023

milla1cf Mon, 04/24/2023 - 14:10 April 24, 2023 — - NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the appointment of Jean-Noel David , MBA, MS, as Vice President, Operations.

Medical 78

Medical Radiopharmaceuticals Pharmaceutical Government 78

AuntMinnie

AUGUST 10, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals is highlighting the completio.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JANUARY 5, 2024

Lu-177 is a medical radioisotope frequently used in radiopharmaceutical therapy to treat cancer. This is a mandatory process needed to obtain pharmaceutical manufacturing authorization. ITM said with the RAM license and other regulatory approvals, the company has achieved operational readiness.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical 52

AuntMinnie

OCTOBER 25, 2023

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Diagnostic Clinic 52

AuntMinnie

SEPTEMBER 11, 2023

Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans t.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

Imaging Technology

JULY 5, 2023

Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Ac-225 and copper-67 (Cu-67) for advancing clinical research and commercial radiopharmaceutical therapy products. Ac-225 to Nucleus. The Company will use its electron accelerator technology to produce n.c.a.

Medical 61

Medical Radiopharmaceuticals Pharmaceutical Radiation 61

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 79

Medical Radiopharmaceuticals Pharmaceutical Radiation 79

Imaging Technology

OCTOBER 11, 2023

As a standalone company, we are keen to collaborate with companies like SOFIE in this way – bringing our size, scale and unique perspective as a developer, of both radiopharmaceuticals and the scanners needed to utilize them, to drive innovation in healthcare to benefit patients and clinicians.” Sherly Mosessian , Ph.D, Sherly Mosessian , Ph.D,

Healthcare 90

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 90

Imaging Technology

AUGUST 28, 2023

This volume would be equivalent to 50% of today’s supply and would underpin the wider development of these targeted alpha therapy radiopharmaceuticals as an effective treatment modality for cancer", commented Sven Van den Berghe, PanTera’s Chief Executive Officer.

Radiopharmaceuticals 92

Radiopharmaceuticals Pharmaceutical Clinic Medical 92

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

OCTOBER 18, 2023

CNL will provide the starting material for irradiation and initially manage the production process during the interim scale of radiochemical grade 225Ac supply, while ITM will further process the resulting 225Ac to pharmaceutical grade under Good Manufacturing Process (GMP) specifications.

Radiopharmaceuticals 91

Radiopharmaceuticals Pharmaceutical Radiation Medical 91

Imaging Technology

NOVEMBER 2, 2023

After regional regulatory approvals, GE HealthCare plans to commercialize the models for use both in pharmaceutical drug development and for clinical decision support. The company recently announced the first patient scanned in a Phase I clinical trial of a first-of-its kind fluorine-18 PET radiopharmaceutical specific for CD8.

Pharmaceutical 59

Pharmaceutical Healthcare Healthcare Clinic 59

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio.

Healthcare 93

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 93